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Background: Albizia adianthifolia is used traditionally in Cameroon to treat several ailments, including infectious
and associated diseases. This work was therefore designed to investigate the antioxidant and antimicrobial activities
of ethyl acetate extract, fractions and compounds isolated from the stem bark of this plant.
Methods: The plant extract was prepared by maceration in ethyl acetate. Its fractionation was done by column
chromatography and the structures of isolated compounds were elucidated using spectroscopic data in
conjunction with literature data. The 1,1-diphenyl-2-picrylhydrazyl (DPPH) and trolox equivalent antioxidant capacity
(TEAC) assays were used to detect the antioxidant activity. Broth micro-dilution method was used for antimicrobial
test. Total phenol content was determined spectrophotometrically in the extracts by using Folin–Ciocalteu method.
Results: The fractionation of the extract afforded two known compounds: lupeol (1) and aurantiamide acetate
(2) together with two mixtures of fatty acids: oleic acid and n-hexadecanoic acid (B1); n-hexadecanoic acid,
octadecanoic acid and docosanoic acid (B2). Aurantiamide acetate was the most active compound. The total
phenol concentration expressed as gallic acid equivalents (GAE) was found to vary from 1.50 to 13.49 μg/ml in the
extracts. The antioxidant activities were well correlated with the total phenol content (R2= 0.946 for the TEAC
method and R2= 0.980 for the DPPH free-radical scavenging assay).
Conclusions: Our results clearly reveal that the ethyl acetate extract from the stem bark of A. adianthifolia
possesses antioxidant and antimicrobial principles. The antioxidant activity of this extract as well as that of
compound 2 are being reported herein for the first time. These results provide promising baseline information for
the potential use of this plant as well as compound 2 in the treatment of oxidative damage and infections
associated with the studied microorganisms.
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Albizia adianthifolia (Schumach) W. F. Wight (Mimo-
soideae), also known as A. chirindensis, A. fastigiata, is a
big tree found in moist and tropical forest zones as well
as areas that are transitional to woodland [1]. This plant
is used in Central and West Africa for the treatment of
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reproduction in any medium, provided the orheadaches and sinusitis [2,3]. Various parts of A.
adianthifolia are traditionally used to treat different dis-
eases. The maceration of stem bark and root is used as
an antidote against poison or applied in pomade on
inflamed eye; the decoction of stem bark is drunk in the
treatment of abdominal pains, typhoid fever and infec-
tions of urinary and respiratory tracts. Some biological
activities exhibited by A. adianthifolia have been docu-
mented. Ethanolic extract of the root of this plant
showed in vitro immunomodulatory activity on the Jur-
kart T cell line and haemolytic property against sheep
erythrocytes [4]. These activities were attributed to theal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adianthifolia has also been reported to contain several
flavonoids [5]. The root extracts of A. adianthifolia
showed antibacterial, anti-inflammatory and anti-
cholinesterase effects [6]. In many developing countries,
the most infectious diseases are of microbial origin. With
the advent of ever-increasing resistant bacterial and yeast
strains, there has been a corresponding rise in the univer-
sal demand for natural antimicrobial therapeutics [7,8].
Microbial infections, especially due to Staphylococcus,
Streptococcus and Pseudomonas species, and the pres-
ence of oxygen free radicals, are known impediments to
wound healing [9]. Any agent capable of eliminating or
reducing the number of microorganisms present in a
wound, as well as reducing the level of reactive oxygen
species (ROS), may facilitate the wound healing process.
It then becomes necessary to search for new antimicro-
bial and antioxidant drugs, especially those that would be
cheap and thus easily affordable by poor population. The
present work was therefore designed to investigate the
antioxidant and antimicrobial activities of ethyl acetate
extract, fractions and compounds isolated from the stem
bark of A. adianthifolia.
Materials and methods
Plant material
The stem bark of A. adianthifolia was collected from
Mbouda (West Region of Cameroon) in January 2010.
The plant material was identified at the Cameroon Na-
tional Herbarium in Yaoundé where a voucher specimen
(N° 19778/SRFCam) was deposited.
Extraction, fractionation and isolation
The stem bark of A. adianthifolia was dried at room
temperature (25 ± 2°C) for three weeks and crushed.
Four kilograms of obtained powder was macerated into
15 l ethyl acetate (Merck) for two days and this process
was repeated twice. After filtration, the filtrate was eva-
porated to dryness at 50°C under reduced pressure using
a rotary evaporator. The dried crude extract (1.75% w/w)
was stored at +4°C. A portion of 60 g of crude extract
was then subjected to column chromatography (22 cm x
8 cm column) using 300 g of silica gel 40 (particle size
0.2-0.5 mm). The column was successively eluted with
hexane (4200 ml), Hexane – EtOAc [19 : 1 (3900 ml), 4 :
1 (4200 ml), 7 : 3 (4800 ml), 3 : 2 (3300 ml), 1 : 1
(3300 ml) and 3 : 7 (6600 ml)] mixtures, ethyl acetate
(4500 ml), ethyl acetate-methanol [19 : 1 (3000 ml), 17 :
3 (3000 ml) and 7 : 3 (1500 ml)] mixtures and methanol
(3900 ml). One hundred and fifty four fractions of
300 ml each were collected and combined on the basis of
their thin layer chromatography (TLC) profiles to afford
nine main fractions. Fractions 1–17, 18–25, 26–40, 41–
54, 55–78, 79–92, 93–124, 125–148 and 149–160 werereferred to as F1, F2, F3, F4, F5, F6, F7, F8 and F9 re-
spectively. These fractions were tested for their anti-
microbial/antioxidant activities and the most active
fractions were further subjected to purification in order
to isolate the active principles. Fraction F2 (2.80 g) was
loaded on a silica gel column (0.063-0.20 mm, 120 g)
eluted with hexane-EtOAc gradients and 37 subfrac-
tions of 100 ml each were collected. Subfractions 1–7
obtained with hexane were purified on a sephadex LH-
20 column eluted with CH2Cl2-MeOH (9:1) to afford
lupeol (45 mg) as yellow crystal. Subfractions 8–20
obtained with hexane-EtOAc (9:1) were purified by CC
on sephadex LH-20 gel eluted with hexane-EtOAc
(8:2) to give the mixture of fatty acids B1 (33 mg):
oleic acid and n-hexadecanoic acid as yellowish crystal.
Subfractions 21–32 obtained with hexane-EtOAc (1:1)
were purified on a sephadex LH-20 column eluted
with hexane-EtOAc (7:3) to yield the mixture of fatty
acids B2 (46 mg): n-hexadecanoic acid, octadecanoic
acid and docosanoic acid as yellowish crystal. Auran-
tiamide acetate (30 mg) was obtained from fraction F4
(17.20 g, eluted with CH2Cl2-EtoAc 19:1) after purifi-
cation by preparative TLC. Fraction F5 (10.30 g)
yielded two individual minor compounds (detected
only on TLC) and a complex mixture.
Identification of the isolated compounds
The structures of the isolated compounds were estab-
lished using spectroscopic analysis, especially, NMR
spectra in conjunction with 2D experiments and by dir-
ect comparison with published information [10,11] and
authentic specimens obtained in our laboratory for some
cases. Melting points (uncorr.) were determined on a
Kofler apparatus. 1H, 2D 1H-1H COSY, 13 C, 2D HMQC
and HMBC spectra were recorded with a Bruker Avance
500 MHz spectrometer. Optical spectra were recorded
with a NICOLET 510 P FT-IR spectrometer, a UV-2101
PC spectrometer, and a Perkin- Elmer 241 polarimeter.
Column chromatography was run on Merck silica gel
60 and gel permeation on sephadex LH-20, while TLC
were carried out either on silica gel GF254 pre-coated
plates (analytical TLC) or on silica gel 60 PF254 con-
taining gypsum (preparative TLC), with detection
accomplished by spraying with 50% H2SO4 followed by
heating at 100°C, or by visualizing with an UV lamp at
254 and 366 nm.
The mixtures of fatty acids were identified by compari-
son of their mass spectra with those available from the
equipment database (Wiley 7 Nist 05.L) and from the
literature. Gas chromatography–mass spectrometry
(GC-MS) data were obtained with an Argilent 6890 N
Network GC system/5975 Inert x L Mass selective De-
tector at 70 eV and 20°C. The GC column was a CP- Sil 8
CB LB, fused silica capillary column (0.25 mm x 30 m,
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50°C for 1 min, and then heated at 10°C/min to 300°C.
The carrier gas was helium at a flow rate of 1.20 ml/min.
Mass spectral data were used to identify fatty acid
fractions.
Determination of total phenol content
Total phenol content was determined spectrophotomet-
rically in the extracts by using Folin–Ciocalteu method
as previously described [12]. The Folin–Ciocalteu re-
agent was prepared by mixing 5 g sodium tungstate,
1.25 g sodium molybdate, 2.50 ml of 85% phosphoric
acid, 10 ml 20% hydrochloric acid, 7.50 g lithium sulfate,
two drops of bromine and deionized water to a final vol-
ume of 50 ml. Further, stock solutions of 20% sodium
carbonate and 400 mg/l gallic acid were added. For each
sample, 20, 10 and 1 μl of 10 mg/ml ethanolic extract or
20 μl of 1 mg/ml ethanolic isolated compounds were
added to 640 μl distilled water and 200 μl freshly pre-
pared Folin–Ciocalteu reagent, followed by incubation in
the dark for 5 min.
Then, 150 μl of 20% sodium carbonate solution were
added and samples were incubated in the dark for
30 min. The solution turned deep blue. The final con-
centration of the tested samples in the assayed solution
was 100 μg/ml and 10 μg/ml for the extracts and iso-
lated compounds respectively. At the same time, gallic
acid standards of 6.25, 12.50, 25, 50 and 75 μg/ml final
concentration solutions were reacted with the Folin–
Ciocalteu reagent in the same way as the samples. The
UV–vis spectra of all the samples were recorded
against the reference solution (zero gallic acid) and the
absorbance was monitored at 725 nm. The measurements
were done in triplicate. For the gallic acid standards, a
calibration curve (Pearson’s correlation coefficient:
R2 = 0.992) was constructed and the total level of phe-
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Figure 1 Chemical structures of lupeol (1) and aurantiamide
acetate (2).Antimicrobial assay
Micro-organisms
The microorganisms used in this study consisted of six
bacteria (Enterococcus faecalis ATCC10541, Staphylococ-
cus aureus ATCC25923, Pseudomonas aeruginosa
ATCC27853, Escherichia coli ATCC11775, Klebsiella
pneumoniae ATCC13883, Salmonella typhi ATCC6539)
and seven fungi (Candida albicans ATCC9002, ATCC2091
and 24433, Candida parapsilosis ATCC22019, C. lusita-
niae ATCC200950, C. tropicalis ATCC750, C. krusei
ATCC6258); all of which are reference strains obtained
from American Type Culture Collection. Also, included
were two clinical isolates of bacteria (Proteus mirabilis,
Shigella flexneri) collected from Pasteur Centre (Yaoundé-Cameroon) and two fungal strains (C. glabbrata IP35,
Cryptococcus neoformans IP95026) obtained from Pas-
teur Institute (IP, Paris-France). The bacterial and yeast
strains were grown at 35°C and maintained on nutrient
agar (NA, Conda, Madrid, Spain) and Sabouraud Dex-
trose Agar (SDA, Conda) slants respectively.Determination of the minimum inhibitory concentration
(MIC) and minimum microbicidal concentration (MMC)
MIC was determined by broth micro dilution method as
previously reported [13]. The inocula of micro-
organisms were prepared from 24 h old broth cultures.
The absorbance was read at 600 nm and adjusted with
sterile physiological solution to match that of a 0.5
McFarland standard solution. From the prepared micro-
bial solutions, other dilutions with sterile physiological
solution were prepared to give a final concentration of
106 colony-forming units (CFU) per millilitre for bac-
teria and 2x105 spores per millilitre for yeasts. Stock
solutions of the extracts (crude extract and fractions)
were prepared in 5% aqueous tween 20 (Fisher chemi-
cals) at concentrations of 50 mg/ml (for crude extract
and fractions) and 1.60 mg/ml (for pure compounds).
The two-fold serial dilutions in concentrations of the
extracts (25–0.048 mg/ml) and pure compounds (800–
0.39 μg/ml) were prepared in Mueller Hinton Broth
(MHB) (Conda, Madrid, Spain) for bacteria and Sabour-
aud Dextrose Broth (SDB) (Conda, Madrid, Spain) for
yeasts. For every experiment, a sterility check (5% aque-
ous tween 20 and medium), negative control (5% aque-
ous tween 20, medium and inoculum) and positive
control (5% aqueous tween 20, medium, inoculum and
water-soluble antibiotics) were included. In general, the
24-macro well plates (Nunclon, Roskilde, Danmark) were
prepared by dispensing into each well 880 μl of an appro-
priate medium, 100 μl of test substances and 20 μl of the
inoculum (106 CFU/ml for bacteria and 5x105 spores/ml
for yeasts). The content of each well was mixed thor-
oughly with a multi-channel pipette and the macro-well
plates were covered with the sterile sealer and incubated
at 35 °C for 24 h (for bacteria) and 48 h (for yeasts) under




Minimum inhibitory concentrations (mg/ml)
Crude extract F2 F3 F4 F5 B1 B2 1 2 References
a
Pseudomonas aeruginosa 0.19 na / 0.19 1.56 na na na 0.10 0.025
Proteus mirabilis 0.39 3.12 1.56 0.39 0.19 0.10 0.40 0.20 0.05 0.10
Klebsiella pneumoniae 0.78 na / 0.39 0.78 na na na 0.05 0.025
Shigella flexneri 0.19 6.25 6.25 0.19 0.39 0.05 0.10 0.10 0.05 0.05
Salmonella typhi 0.09 3.12 3.12 0.04 0.39 0.20 0.40 na 0.10 0.05
Escherichia coli 0.78 na / 0.78 1.56 na na na 0.05 0.025
Staphylococcus aureus 0.09 3.12 3.12 0.09 0.78 0.20 0.80 0.20 0.05 0.05
Enterococcus faecalis 0.78 3.12 3.12 0.04 0.39 0.40 0.20 0.40 0.10 0.012
Yeasts
Candida albicans ATCC 9002 1.56 na / 1.56 3.12 0.20 0.40 0.40 0.025 0.001
Candida albicans ATCC 2091 3.12 na / 0.39 0.78 / / / 0.025 0.0015
Candida albicans ATCC 24433 0.78 3.12 3.12 0.78 1.56 / / / 0.05 0.001
Candida parapsilosis 3.12 na 1.56 3.12 6.25 / / 0.20 0.006 0.01
Candida tropicalis 6.25 na na 6.25 na 0.40 0.10 / 0.006 0.006
Candida krusei 1.56 na na 0.78 na / / 0.40 0.012 0.003
Candida glabbrata 1.56 na na 1.56 na / / / 0.025 0.012
Candida lusitaniae 0.39 1.56 1.56 0.09 0.78 0.10 0.20 0.10 0.05 0.001
Cryptococcus neoformans 0.78 6.25 3.12 0.39 1.56 0.20 0.40 0.20 0.006 0.001
The results are the mean values of triplicate tests measured after 24–48 h incubation at 35 ° C; na: not active; /: not tested; agentamicin and nystatin were used as
reference antibiotics for bacteria and yeasts respectively; B1: Oleic acid and n-hexadecanoid acid; B2: n-hexadecanoic acid, octadecanoic acid and docosanoic acid;
1: lupeol; 2: aurantiamide acetate.
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many) at 300 rpm. Microbial growth in each well was
determined by observing and comparing the test wells
with the positive and negative controls. The absence of
microbial growth was interpreted as the antibacterial or
antifungal activities. The MIC was the lowest concentra-
tion of the test substances that prevented visible growth
of micro-organisms. Minimum Bactericidal Concentra-
tions (MBCs) or Minimum Fungicidal Concentrations
(MFCs) were determined by plating 10 μl from each
negative well and from the positive growth control on
Mueller Hinton Agar (for bacteria) and Sabouraud
Dextrose Agar (for yeasts). MBCs or MFCs were
defined as the lowest concentration yielding negative
subcultures or only one colony. All the experiments
were performed in triplicate. Gentamicin and nystatin
at the concentration ranging between 400 and 0.78 μg/ml%decolouration of DPPH ¼ Absorbance of control  Abð
Absorbanserved as positive controls for antibacterial and antifungal
activities respectively.
Antioxidant assay
DPPH free radical scavenging assay
The free radical scavenging activity of the extracts as well
as their isolated compounds was evaluated according to
described methods [14]. Briefly, the test samples, prior
dissolved in DMSO (SIGMA) beforehand, were mixed
with a 20 mg/l 2,2-diphenyl-1-picryl-hydrazyl (DPPH)
methanol solution, to give final concentrations of 10, 50,
100, 500 and 1000 μg/ml. After 30 min at room
temperature, the absorbance values were measured at
517 nm and converted into percentage of antioxidant
activity. L-ascorbic acid was used as a standard control.
The percentage of decolouration of DPPH (%) was cal-
culated as follows:sorbance of test sampleÞ X100
ce of control
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plotted against the test sample. Also, the percentage of
decolouration of DPPH was converted in probits. The
probit values were plotted against the logarithmic values
of concentrations of the test samples and a linear regres-
sion curve was established in order to calculate the EC50
(μg/ml), which is the amount of sample necessary to de-
crease by 50% the absorbance of DPPH. All the analysis
were carried out in triplicate.
Trolox equivalent antioxidant capacity (TEAC) assay
The TEAC test was done as previously described [15]
with slight modifications. In a quartz cuvette, to 950 μl
acetate buffer (pH =5.0, 100 mM), the following were
added: 20 μl laccase (1 mM stock solution), 20 μl test
sample, 10 μl ABTS (2,2'-azinobis(3-ethylbenzothiazoline-
6-sulfonic acid)) (74 mM stock solution). The sample
concentrations in the assay mixture were 200, 100, 10 μg/
ml for the extracts and 20 μg/ml for the isolated com-
pounds. The content of the generated ABTS●+ radical
was measured at 420 nm after 230 s reaction time and
was converted to gallic acid equivalents by the use of a
calibration curve (Pearson’s correlation coefficient:
R2 = 0.997) constructed with 0, 4, 10, 14, 28, 56, 70 μM
gallic acid standards rather than Trolox. Experiments





Crude extract F2 F3 F
Pseudomonas aeruginosa 0.39 na / 0
Proteus mirabilis 0.78 3.12 3.12 0
Klebsiella pneumoniae 1.56 na / 0
Shigella flexneri 0.39 6.25 6.25 0
Salmonella typhi 0.19 3.12 3.12 0
Escherichia coli 1.56 na / 1
Staphylococcus aureus 0.39 3.12 3.12 0
Enterococcus faecalis 0.78 3.12 3.12 0
Yeasts
Candida albicans ATCC 9002 3.12 na / 3
Candida albicans ATCC 2091 6.25 na / 1
Candida albicans ATCC 24433 1.56 3.12 3.12 1
Candida parapsilosis 6.25 na 1.56 3
Candida tropicalis 6.25 na na 6
Candida krusei 3.12 na na 1
Candida glabbrata 3.12 na na 1
Candida lusitaniae 0.78 3.12 3.12 0
Cryptococcus neoformans 0.78 6.25 6.25 0
The results are the mean values of triplicate tests measured after 24–48 h incubatio
reference antibiotics for bacteria and yeasts respectively; B1: Oleic acid and n-hexad
1: lupeol; 2: aurantiamide acetate.Statistical analysis
Statistical analysis was carried out using Statistical Pack-
age for Social Science (SPSS, version 12.0). The experimen-
tal results were expressed as the mean±Standard Deviation
(SD). Group comparisons were performed using One Way
ANOVA followed by Waller-Duncan Post Hoc test. A
p value of 0.05 was considered statistically significant.
Results
Phytochemical analysis
Two known compounds: lupeol (1) and aurantiamide acet-
ate (2) and two main mixtures of fatty acids (B1: oleic acid
and n- hexadecanoic acid; B2: n-hexadecanoic acid, octade-
canoic acid and docosanoic acid were isolated from ethyl
acetate extract of A. adianthifolia stem bark. The struc-
tures of compounds 1 and 2 are presented on Figure 1.Antimicrobial activity
In this study, the antibacterial and antifungal activities of
the crude extract, fractions and the isolated compounds
were evaluated. The broth micro dilution method was
applied to 17 microorganisms including fungi from Can-
dida and Cryptococcus genus, gram-positive and gram
negative bacteria. The results summarized in Tables 1
and 2 showed that the crude extract, fractions F2-F5,tract, fractions and compounds isolated from
(mg/ml)
4 F5 B1 B2 1 2 References
a
.39 3.12 na na na 0.10 0.025
.39 0.39 0.20 0.80 0.20 0.05 0.10
.39 1.56 na na na 0.05 0.025
.39 0.39 0.10 0.20 0.20 0.05 0.05
.09 0.39 0.40 0.80 na 0.10 0.05
.56 1.56 na na na 0.05 0.025
.09 1.56 0.20 0.80 0.20 0.05 0.05
.09 0.39 0.40 0.20 0.40 0.10 0.012
.12 6.25 >0.80 0.80 0.40 0.025 0.001
.56 1.56 / / / 0.025 0.0015
.56 3.12 / / / 0.05 0.001
.12 6.25 / / 0.20 0.012 0.01
.25 na >0.80 0.20 / 0.025 0.006
.56 na / / 0.40 0.012 0.03
.56 na / / / 0.05 0.012
.19 0.78 >0.80 0.40 0.20 0.05 0.001
.78 3.25 >0.80 0.80 0.20 0.006 0.001
n at 35 ° C; na: not active; /: not tested; agentamicin and nystatin were used as
ecanoid acid; B2: n-hexadecanoic acid, octadecanoic acid and docosanoic acid;
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prevented the growth of most of the tested microorgan-
isms. The MIC values obtained varied from 0.006 to
6.25 mg/ml and 0.04 to 6.25 mg/ml for yeasts and bac-
teria respectively (Table 1). The lowest MIC value
(0.006 mg/ml) was recorded with compound 2 on Can-
dida parapsilosis, Candida tropicalis and Cryptococcus
neoformans. The inhibition effects of the crude extract,
fraction F4 and compound 2 were observed on all the
tested microorganisms (100%). Those of fractions F2, F3,
F5, B1, B2 and compound 1 were respectively noted on 8
(47.5%), 9 (52.94%), 14 (82.35%), 9 (52.94%), 9 (52.94%)
and 9 (52.94%) of the 17 tested microbial species. The
results of the MMC determination (Table 2) also indi-
cated a detectable MMC value within the tested interval
for crude extract, fractions and compounds on several
tested microorganisms. Compound 2 was the most ac-
tive sample. Moreover, its MIC values were often equal
to or lower than those of reference drugs gentamicin
and nystatin. Proteus mirabilis, Shigella flexneri,
Staphylococcus aureus and Enterococcus faecalis were in
general found to be the most sensitive bacteria speciesFigure 2 Total phenol content expressed as gallic acid equivalents (G
mean± SD of three independent experiments carried out in triplicate. Lette
one way ANOVA and Waller Duncan test; p<0.05.while Candida lusitaniae and Cryptococcus neoformans
showed the best susceptibility amongst the yeasts tested
(Table 1). The MICs were generally four-fold less than
the corresponding MMCs (Tables 1 and 2). The crude
extract was more effective on bacteria as compare to
fungi. Fractionation enhanced the antimicrobial activity
of the crude extract in fraction F4. However, these ac-
tivities decreased in fractions F2, F3 and F5. No activity
(MIC >12.50 mg/ml) was noticed in fractions F1, F6,
F7, F8 and F9 for all the microorganisms tested (not
shown).
Total phenol content
The Folin-Ciocalteu assay is one of the oldest methods
developed to determine the content of total phenols
[16]. In this work, the total phenol content of crude ex-
tract and fractions from A. adianthifolia stem bark was
analyzed. As shown in Figure 2, the total phenol content
expressed as gallic acid equivalents (GAE) was found to
vary from 1.50 to 13.49 μg/ml in the extracts. Also, the
fractionation increased the total phenol content of the
crude extract (GAE: 3.95 μg/ml) in fractions F2, F3 andAE; μg/ml) in crude extract and fractions. Bars represent the
rs a - e indicate significant differences between samples according to
Tamokou et al. BMC Complementary and Alternative Medicine 2012, 12:99 Page 7 of 10
http://www.biomedcentral.com/1472-6882/12/99F4 (GAE: 7.42, 13.49 and 12.56 μg/ml respectively); but
the amount was low in fraction F5 (GAE: 1.50 μg/ml).Antioxidant activity
Both with DPPH and TEAC methods, aurantiamide
acetate (EC50 = 9.51 μg/mL; TEAC= 78.81 μg/mL)
showed the highest antioxidant activity (AOA) followed
in decreasing order by fraction 3 (EC50 = 26.30 μg/mL;
TEAC= 61.60 μg/mL), fraction 4 (EC50 = 30.11 μg/mL;
TEAC= 55.95 μg/mL), fraction 2 (EC50 = 32.35 μg/mL;
TEAC=50.32 μg/mL), crude extract (EC50 = 70.11 μg/mL;
TEAC=46.72 μg/mL) and fraction 5 (EC50 = 77.75 μg/mL;
TEAC=39.10 μg/mL) (Figures 3 and 4). However, the
AOA of aurantiamide acetate (EC50= 9.51 μg/mL) was
significantly (p<0.05) lower than that of L-ascorbic acid
(EC50= 6.81 μg/mL) used as reference antioxidant com-
pound (Figure 3). Fractionation enhanced the AOA of the
crude extract in fractions F2, F3 and F4; but this activityFigure 3 Equivalent concentrations of test samples scavenging 50% o
independent experiments carried out in triplicate. Letters a - g indicate sign
and Waller Duncan test; p< 0.05.was low in fractions F5 (Figures 3 and 4). Fractions F1 and
F6- F9 were not active (not shown).
Correlation between the antioxidant capacity and the
total phenol content
The AOAs were well correlated with the total phenol
content: R2= 0.946 for the TEAC method and R2= 0.980
for the DPPH free-radical scavenging assay (Figure 5).
Discussion
The findings of the present study showed that there
were differences between the antimicrobial/antioxidant
activities of crude extract and those of fractions. Frac-
tions F2-F4 (for antioxidant activity) and F4 (for anti-
microbial activity) were more active than the crude
extract indicating that fractionation enhanced the con-
sidered biological activities of these fractions. This may
be due to the exclusion by fractionation of some consti-
tuents of the extract which may tend to dilute the activef DPPH radical (EC50). Bars represent the mean± SD of three
ificant differences between samples according to one way ANOVA
Figure 4 Gallic acid equivalent antioxidant capacity (TEAC; μg/ml) of tested samples. Bars represent the mean± SD of three independent
experiments carried out in triplicate. Letters a-f indicate significant differences between samples according to one way ANOVA and Waller
Duncan test; p<0.05.
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fractionation may have increased the concentrations and
the activities of antimicrobial/antioxidant principles in
these fractions. Our results partially justify theFigure 5 Positive correlations between the TEAC (A) or EC50 (B) and t
independent experiments performed in triplicate. TEAC: gallic acid equivale
samples scavenging 50% of DPPH radical.traditional use of this plant for the treatment of skin dis-
eases, bronchitis, typhoid fever and infections of urinary
and respiratory tracts that can be caused by the tested
microorganisms. The data showed that the response inotal phenol content. Results represent the mean± SD of three
nt antioxidant capacity, EC50: equivalent concentration of the test
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http://www.biomedcentral.com/1472-6882/12/99terms of susceptibility to tested plant extracts/isolated
compounds varied among the strains. These variations
may be due to genetic differences between the strains. It
was also found that MMC values (Table 2) obtained
were generally less than four-fold greater than the MICs
(Table 1) on the corresponding microbial species, sug-
gesting that the killing effects of the crude extract and
the isolated compounds could be expected on most of
the tested micro-organisms [13,17,18]. This is very inter-
esting in the perspective of developing antimicrobial
drugs from the tested samples. Subfractions B1 and B2
showed antimicrobial activity against yeasts and bacteria.
This is not surprising since some lipid fractions and in-
dividual fatty acids have shown this type of biological ac-
tivities [19,20]. Compounds 1 and 2 displayed both
antibacterial and antifungal activities. Comparable
results were reported [21,22].
The antioxidant activities of ethyl acetate extract of A.
adianthifolia stem bark corroborate those reported on
the stem bark of Albizia julibrissin [23]. Numerous
examples of the application of the Folin-Ciocalteu assay
to characterize natural products may be found in litera-
ture. In most cases, total phenols determined by this
method are correlated with the antioxidant capacities
confirming the value of the Folin-Ciocalteu test [24]. A
new enzymatic method involoving the use of horseradish
peroxidase and 4-aminoantipyrine has recently been
used in a comparative study of total polyphenol content
of tea. Significant differences were found in the results
obtained by the Folin-Ciocalteu and enzymatic methods
indicating that the enzymatic method needs further
standardization [25]. In addition to the compound 2,
phenolic and other nitrogenous compounds were previ-
ously isolated from A. adianthifolia [4,5]. Phenolic and
nitrogenous compounds are known to be potential anti-
oxidant due to their ability to scavenge free radicals and
active oxygen species such as singlet oxygen, super-
oxide anion radical and hydroxyl radicals [26,27].
Therefore, the presence of such compounds could be
responsible for the antioxidant activity found in the
crude extract and fractions. To the best of our know-
ledge, this is the first systematic screening for the
quantification of phenols and antioxidant activity of
the crude extract, fractions and compounds from A.
adianthifolia.
The overall results of this study can be considered as
very promising in the perspective of new drugs discovery
from plant sources, when considering the medical import-
ance of tested microorganisms as well as the high level of
neurodegenerative diseases associated with oxidative
stress. Pseudomonas aeruginosa has emerged as one of the
most problematic gram-negative pathogens, with the
alarmingly high antibiotics resistance rates [28,29]. Even
with the most effective antibiotic (carbapenems) againstthis pathogen, the resistance rates were detected as 15–
20.40% amongst 152 Pseudomonas aeruginosa strains
[29]. This pathogen was found to be sensitive to the crude
extract. Staphylococcus aureus is a major cause of commu-
nity and hospital-associated infection with an estimated
mortality of around 7-10% [30]. About 77% of immune-
deficient patients’ death is attributable to microscopic
fungi, such as Candida species and Cryptococcus neofor-
mans [31]. The prevalence of the typhoid fever caused by
Salmonella typhi is increased in developing country now-
adays [13]. Such findings trace the importance of discov-
ery new substances against which these organisms are
sensitive. Generally, at least one sample tested in this
study prevented the growth of each microbial strain.
Conclusions
The results of the present study provide an important
basis for use of A. adianthifolia in the treatment of oxi-
dative damages and infections associated with the stud-
ied microorganisms. The ethyl acetate extract, fractions
F2, F3 and F4 as well as aurantiamide acetate found to
be the most active samples in this study could be useful
for the development of new antimicrobial and antioxi-
dant substances.
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